Home Lengo Therapeutics

Lengo Therapeutics

acquired
Series A
Cancer Drug Developer

Basic Information

Lengo Therapeutics is a biopharmaceutical company focused on the discovery and development of cancer treatments. Lengo is committed to identifying several cancer mutations that existing therapies have not addressed well, helping doctors and pharmaceutical companies target driver mutations in oncology.
Lengo Therapeutics Inc.
SanDiego,California,United States of America
less than 15 people
February 14, 2019
info@lengotx.com